GAFFX
Price
$85.14
Change
+$0.99 (+1.18%)
Updated
Jul 31 closing price
Net Assets
356.86B
LGLUX
Price
$58.39
Change
+$0.49 (+0.85%)
Updated
Jul 31 closing price
Net Assets
7.43B
Interact to see
Advertisement

GAFFX vs LGLUX

GAFFX vs LGLUX Comparison Chart in %
View a ticker or compare two or three
VS
GAFFX vs. LGLUX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and LGLUX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 357B vs. LGLUX (7.43B). GAFFX pays higher dividends than LGLUX: GAFFX (0.53) vs LGLUX (0.00). GAFFX was incepted earlier than LGLUX: GAFFX (10 years) vs LGLUX (11 years). LGLUX (0.64) is less costly to investors than GAFFX (0.29). LGLUX is a more actively managed with annual turnover of: 72.00 vs. GAFFX (32.00). LGLUX has a lower initial minimum investment than GAFFX: LGLUX (0) vs GAFFX (1000000). LGLUX annual gain was more profitable for investors over the last year : 4.32 vs. GAFFX (1.95). LGLUX return over 5 years is better than : 16.52 vs. GAFFX (15.04).
GAFFXLGLUXGAFFX / LGLUX
Total Expense Ratio0.290.6445%
Annual Report Gross Expense Ratio0.290.6445%
Fund Existence10 years11 years-
Gain YTD5.7902.817206%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets357B7.43B4,804%
Annual Yield % from dividends0.530.00-
Returns for 1 year1.954.3245%
Returns for 3 years37.3779.3347%
Returns for 5 years15.0416.5291%
Returns for 10 yearsN/A153.76-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGSX27.210.13
+0.48%
BlackRock Advantage Global R
PXEAX23.770.09
+0.38%
Impax Global Environmental Markets A
PMVEX33.70-0.09
-0.27%
PGIM Quant Solutions Mid-Cap Val R2
RYMKX78.94-0.61
-0.77%
Rydex Russell 2000 1.5x Strategy H
SHSCX45.68-0.51
-1.10%
BlackRock Health Sciences Opps Inv C